The new Leiomyosarcoma Project joins an existing effort, Count Me In’s Osteosarcoma Project, to partner with patients and accelerate scientific discovery in rare cancers.
New map of chronic lymphocytic leukemia could potentially help identify new diagnostic markers, offer more accurate prognoses, and develop novel treatments.
Anne Carpenter and Shantanu Singh discuss how they are expanding the uses of their image-based profiling method, Cell Painting, to speed up drug discovery and predict gene function.
Scientists have solved the structure of an important complex of RAS-pathway proteins, explaining how known mutations lead to disease and suggesting potential new binding sites for cancer drugs.
By introducing cancer-causing mutations into healthy skin cells step-by-step, Broad scientists have created models of skin cancer that can reveal the effects of mutations.